Concepedia

C. Garrett Rappazzo

CG

14

Publications

1.2K

Citations

14

H-Index

2016

Active since

Affiliations

Adimab (United States)(Current)

The University of Texas at Austin

The Geneva Foundation

Massachusetts Institute of Technology

United States Army Medical Research Institute of Infectious Diseases

C. Garrett Rappazzo is an author at Adimab (United States) specializing in vaccination, medicine, and immunology.

ORCID

Top concepts

Publications per year

2016–2023

14

Publications

14

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku et al. · Science · 2021 · 382 citations · Full text

Prolonged evolution of the human B cell response to SARS-CoV-2 infection

Mrunal Sakharkar, C. Garrett Rappazzo, Wendy Wieland‐Alter et al. · Science Immunology · 2021 · 199 citations · Full text

Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice

C. Garrett Rappazzo, Hannah C. Watkins, Cassandra Guarino et al. · Vaccine · 2016 · 136 citations

, , +11

Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection

Hannah C. Watkins, C. Garrett Rappazzo, Jaclyn S. Higgins et al. · Molecular Therapy · 2017 · 102 citations · Full text

IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development

Amy Li, Rebecca H. Herbst, David Canner et al. · Cell Reports · 2019 · 78 citations · Full text

Rows per page

1–5 of 14